Health Care & Life Sciences » Biotechnology | RXi Pharmaceuticals Corp.

RXi Pharmaceuticals Corp. | Ownership

Companies that own RXi Pharmaceuticals Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Sabby Capital LLC
168,462
3.85%
168,462
0.13%
06/30/2018
SG Americas Securities LLC
118,387
2.71%
118,387
0%
06/30/2018
The Vanguard Group, Inc.
25,660
0.59%
7,363
0%
06/30/2018
DRW Securities LLC
19,000
0.43%
0
0%
06/30/2018
Virtu Financial BD LLC
12,073
0.28%
-8,751
0%
06/30/2018
First Allied Advisory Services, Inc.
11,019
0.25%
-9,000
0%
06/30/2018
Intellectus Partners LLC
10,000
0.23%
5,000
0%
06/30/2018
HighTower Advisors LLC
10,000
0.23%
0
0%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
5,718
0.13%
5,718
0%
06/30/2018
Edmond de Rothschild (Suisse) SA (Investment Management)
4,690
0.11%
4,690
0%
06/30/2018

About RXi Pharmaceuticals

View Profile
Address
257 Simarano Drive
Marlborough Massachusetts 01752
United States
Employees -
Website http://www.rxipharma.com
Updated 09/14/2018
RXi Pharmaceuticals Corp. is a biotechnology company, which engages in developing therapeutics that address unmet medical needs. Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.